Vancomycin-Resistant Enterococci - 03/10/13
, Yoav Keynan, MDRésumé |
Vancomycin-resistant enterococci (VRE) consist mainly of Enterococcus faecalis and E faecium, the latter mostly hospital-acquired. In addition, E gallinarum and E casseliflavus are intrinsically vancomycin-resistant and are community-acquired. VRE have become common in many hospitals throughout the world and, once established, are very difficult to eradicate. VRE are difficult to treat; therefore, infection control measures in hospitals are of prime importance in preventing the establishment of these pathogens. Most severe VRE infections will need combination therapy because many of the effective antimicrobial agents, when used alone, have only a bacteriostatic effect.
Le texte complet de cet article est disponible en PDF.Keywords : Vancomycin, Enterococcus, Resistant pathogen, Gram-positive cocci, Critical care, Infection
Plan
| Disclosure: Dr Ethan Rubinstein is an advisor to Trius and Bayer. |
Vol 29 - N° 4
P. 841-852 - octobre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
